A company pioneering a drug to delay cataracts from forming or slow their growth has won this year’s $100,000 Enterprize competition. Adelaide-based Calpain Therapeutics’ victory was announced earlier this month by University of Queensland Business School, which has run Australia’s richest business-plan contest since 2000.
On World Sight Day, judges of the University of Queensland (UQ) Business School’s $100,000 Enterprize competition finals voted resoundingly for an innovation that could control the world’s single largest cause of blindness – cataract, a clouding of the eye’s lens among older populations. Calpain Therapeutics, an Adelaide startup that has developed a drug that can slow the onset of cataract, won the nation’s richest business plan competition, ahead of four others shortlisted.
End of content
End of content
GET THIS AMAZEBALLS THING!
Click the button to get it now
